50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.50 (-0.21%)
DOW   29,136.51 (-0.42%)
QQQ   274.83 (+0.17%)
AAPL   151.98 (+0.80%)
MSFT   236.80 (-0.27%)
META   134.70 (-1.22%)
GOOGL   97.64 (-0.54%)
AMZN   114.71 (-0.38%)
TSLA   283.18 (+2.60%)
NVDA   124.18 (+1.55%)
NIO   17.25 (-2.10%)
BABA   77.95 (-1.22%)
AMD   67.16 (+1.30%)
T   15.73 (+0.38%)
MU   50.45 (+3.21%)
CGC   2.85 (+4.01%)
F   11.91 (-0.67%)
GE   64.55 (+0.31%)
DIS   95.98 (-2.18%)
AMC   7.48 (+9.52%)
PYPL   85.73 (+1.74%)
PFE   44.12 (+0.66%)
NFLX   225.34 (+0.57%)
S&P 500   3,647.50 (-0.21%)
DOW   29,136.51 (-0.42%)
QQQ   274.83 (+0.17%)
AAPL   151.98 (+0.80%)
MSFT   236.80 (-0.27%)
META   134.70 (-1.22%)
GOOGL   97.64 (-0.54%)
AMZN   114.71 (-0.38%)
TSLA   283.18 (+2.60%)
NVDA   124.18 (+1.55%)
NIO   17.25 (-2.10%)
BABA   77.95 (-1.22%)
AMD   67.16 (+1.30%)
T   15.73 (+0.38%)
MU   50.45 (+3.21%)
CGC   2.85 (+4.01%)
F   11.91 (-0.67%)
GE   64.55 (+0.31%)
DIS   95.98 (-2.18%)
AMC   7.48 (+9.52%)
PYPL   85.73 (+1.74%)
PFE   44.12 (+0.66%)
NFLX   225.34 (+0.57%)
S&P 500   3,647.50 (-0.21%)
DOW   29,136.51 (-0.42%)
QQQ   274.83 (+0.17%)
AAPL   151.98 (+0.80%)
MSFT   236.80 (-0.27%)
META   134.70 (-1.22%)
GOOGL   97.64 (-0.54%)
AMZN   114.71 (-0.38%)
TSLA   283.18 (+2.60%)
NVDA   124.18 (+1.55%)
NIO   17.25 (-2.10%)
BABA   77.95 (-1.22%)
AMD   67.16 (+1.30%)
T   15.73 (+0.38%)
MU   50.45 (+3.21%)
CGC   2.85 (+4.01%)
F   11.91 (-0.67%)
GE   64.55 (+0.31%)
DIS   95.98 (-2.18%)
AMC   7.48 (+9.52%)
PYPL   85.73 (+1.74%)
PFE   44.12 (+0.66%)
NFLX   225.34 (+0.57%)
S&P 500   3,647.50 (-0.21%)
DOW   29,136.51 (-0.42%)
QQQ   274.83 (+0.17%)
AAPL   151.98 (+0.80%)
MSFT   236.80 (-0.27%)
META   134.70 (-1.22%)
GOOGL   97.64 (-0.54%)
AMZN   114.71 (-0.38%)
TSLA   283.18 (+2.60%)
NVDA   124.18 (+1.55%)
NIO   17.25 (-2.10%)
BABA   77.95 (-1.22%)
AMD   67.16 (+1.30%)
T   15.73 (+0.38%)
MU   50.45 (+3.21%)
CGC   2.85 (+4.01%)
F   11.91 (-0.67%)
GE   64.55 (+0.31%)
DIS   95.98 (-2.18%)
AMC   7.48 (+9.52%)
PYPL   85.73 (+1.74%)
PFE   44.12 (+0.66%)
NFLX   225.34 (+0.57%)
NASDAQ:XCUR

Exicure - XCUR Stock Forecast, Price & News

$1.41
-0.29 (-17.06%)
(As of 09/27/2022 03:48 PM ET)
Add
Compare
Today's Range
$1.40
$1.72
50-Day Range
$1.53
$2.50
52-Week Range
$1.47
$40.50
Volume
22,681 shs
Average Volume
80,793 shs
Market Capitalization
$6.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.50

Exicure MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
4,555.2% Upside
$67.50 Price Target
Short Interest
Healthy
2.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.57mentions of Exicure in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

XCUR stock logo

About Exicure (NASDAQ:XCUR) Stock

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

XCUR Stock News Headlines

Exicure (XCUR) Investor Presentation - Slideshow
See More Headlines
Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

XCUR Company Calendar

Last Earnings
11/19/2021
Today
9/27/2022
Next Earnings (Estimated)
11/18/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:XCUR
Fax
N/A
Employees
47
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$67.50
High Stock Price Forecast
$67.50
Low Stock Price Forecast
$67.50
Forecasted Upside/Downside
+4,687.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-64,100,000.00
Pretax Margin
-1,529.31%

Debt

Sales & Book Value

Annual Sales
$16.61 million
Book Value
$3.10 per share

Miscellaneous

Free Float
4,546,000
Market Cap
$6.99 million
Optionable
Not Optionable
Beta
1.45

Key Executives

  • Dr. Matthias G. Schroff Ph.D. (Age 53)
    CEO, Pres & Director
    Comp: $479.09k
  • Mr. Brian C. Bock (Age 45)
    Special Advisor
    Comp: $449.29k
  • Mr. Elias D. PapadimasMr. Elias D. Papadimas (Age 46)
    CFO & Corp. Sec.
  • Ms. Sarah Longoria (Age 40)
    Chief HR & Compliance Officer
  • Mr. Bart Anderson
    Sr. Director of R&D













XCUR Stock - Frequently Asked Questions

Should I buy or sell Exicure stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exicure in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" XCUR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XCUR, but not buy additional shares or sell existing shares.
View XCUR analyst ratings
or view top-rated stocks.

What is Exicure's stock price forecast for 2022?

1 analysts have issued 12-month price objectives for Exicure's shares. Their XCUR share price forecasts range from $67.50 to $67.50. On average, they expect the company's share price to reach $67.50 in the next twelve months. This suggests a possible upside of 4,311.8% from the stock's current price.
View analysts price targets for XCUR
or view top-rated stocks among Wall Street analysts.

How have XCUR shares performed in 2022?

Exicure's stock was trading at $6.0630 on January 1st, 2022. Since then, XCUR shares have decreased by 74.8% and is now trading at $1.53.
View the best growth stocks for 2022 here
.

When is Exicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 18th 2022.
View our XCUR earnings forecast
.

How were Exicure's earnings last quarter?

Exicure, Inc. (NASDAQ:XCUR) posted its quarterly earnings results on Friday, November, 19th. The company reported ($8.10) earnings per share for the quarter, missing the consensus estimate of ($2.70) by $5.40. The business had revenue of ($3.68) million for the quarter, compared to analysts' expectations of $0.80 million.

When did Exicure's stock split?

Exicure shares reverse split on Thursday, June 30th 2022. The 1-30 reverse split was announced on Thursday, June 30th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What is Exicure's stock symbol?

Exicure trades on the NASDAQ under the ticker symbol "XCUR."

Who are Exicure's major shareholders?

Exicure's stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (1.99%), Northwestern University (1.27%) and Virtu Financial LLC (0.30%). Insiders that own company stock include Aurasense Llc, Bali Muralidhar, Elias D Papadimas and Gates Frontier, Llc.
View institutional ownership trends
.

How do I buy shares of Exicure?

Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exicure's stock price today?

One share of XCUR stock can currently be purchased for approximately $1.53.

How much money does Exicure make?

Exicure (NASDAQ:XCUR) has a market capitalization of $7.59 million and generates $16.61 million in revenue each year. The company earns $-64,100,000.00 in net income (profit) each year or ($16.3747) on an earnings per share basis.

How can I contact Exicure?

Exicure's mailing address is 2430 N. Halsted St., Chicago IL, 60614. The official website for the company is www.exicuretx.com. The company can be reached via phone at (847) 673-1700 or via email at ir@exicuretx.com.

This page (NASDAQ:XCUR) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.